155 related articles for article (PubMed ID: 35519002)
1. High glucocorticoid receptor expression in the sarcomatous versus carcinomatous elements of Mullerian carcinosarcomas.
Kurnit KC; Steiner M; Lastra RR; Weroha SJ; Cursio J; Lengyel E; Fleming GF; Conzen SD
Gynecol Oncol Rep; 2022 Jun; 41():100987. PubMed ID: 35519002
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of the epithelial to mesenchymal transition in uterine carcinosarcoma.
Osakabe M; Fukagawa D; Sato C; Sugimoto R; Uesugi N; Ishida K; Itamochi H; Sugiyama T; Sugai T
Int J Gynecol Cancer; 2019 Feb; 29(2):277-281. PubMed ID: 30636710
[TBL] [Abstract][Full Text] [Related]
3. PReferentially Expressed Antigen in MElanoma Expression in Uterine and Ovarian Carcinosarcomas.
Alrohaibani A; Yu Y; Gao L; McLean KM; Hetts J; Saglam O
Int J Gynecol Pathol; 2024 May; 43(3):284-289. PubMed ID: 38085958
[TBL] [Abstract][Full Text] [Related]
4. FOXA1 Expression by Immunohistochemistry in Carcinosarcomas of the Endometrium and Ovary/Fallopian Tube.
Karpathiou G; Chauleur C; Dal Col P; Peoc'h M
Int J Gynecol Pathol; 2021 Nov; 40(6):611-616. PubMed ID: 33770058
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of carcinomatous and sarcomatous components in the uterine carcinosarcoma: a case report.
Semczuk A; Skomra D; Chyzyńska M; Szewczuk W; Olcha P; Korobowicz E
Pathol Res Pract; 2008; 204(3):203-7. PubMed ID: 18207653
[TBL] [Abstract][Full Text] [Related]
6. Folate Receptor Alpha Is Preferentially Expressed in the Carcinoma Component of Endometrial Carcinosarcomas: A Potential Target for Adjuvant Therapy.
Hanley KZ; Horowitz IR; Gordon A; Meisel J; Khanna N
Int J Gynecol Pathol; 2021 Sep; 40(5):501-509. PubMed ID: 33323854
[TBL] [Abstract][Full Text] [Related]
7. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
Costa MJ; Guinee D
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
[TBL] [Abstract][Full Text] [Related]
8. Is the sarcomatous component (homologous vs heterologous) the prognostic "driving force" in early-stage uterine carcinosarcomas? A retrospective multicenter study.
Rosati A; Vargiu V; Certelli C; Arcieri M; Vizza E; Legge F; Cosentino F; Ferrandina G; Fanfani F; Scambia G; Corrado G
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6479-6488. PubMed ID: 36773091
[TBL] [Abstract][Full Text] [Related]
9. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.
Soslow RA; Ali A; Oliva E
Am J Surg Pathol; 2008 Jul; 32(7):1013-21. PubMed ID: 18469708
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of matrix metalloprotease-7 in each component of uterine carcinosarcoma.
Tanimoto H; Shigemasa K; Sasaki M; Katayama H; Kusumi I; Parmley TH; O'Brien TJ; Ohama K
Oncol Rep; 2000; 7(6):1209-12. PubMed ID: 11032915
[TBL] [Abstract][Full Text] [Related]
11. Mutational and Immunophenotypic Profiling of a Series of 8 Tubo-ovarian Carcinosarcomas Revealed a Monoclonal Origin of the Disease.
Trento M; Munari G; Carraro V; Lanza C; Salmaso R; Pizzi S; Santoro L; Chiarelli S; Dal Santo L; Nardelli GB; Saccardi C; Nicoletto O; Baldoni A; Rugge M; Fassan M
Int J Gynecol Pathol; 2020 Jul; 39(4):305-312. PubMed ID: 31688243
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary carcinosarcoma: immunohistochemical and ultrastructural studies.
Haraguchi S; Fukuda Y; Sugisaki Y; Yamanaka N
Pathol Int; 1999 Oct; 49(10):903-8. PubMed ID: 10571825
[TBL] [Abstract][Full Text] [Related]
13. Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition.
Zhao S; Bellone S; Lopez S; Thakral D; Schwab C; English DP; Black J; Cocco E; Choi J; Zammataro L; Predolini F; Bonazzoli E; Bi M; Buza N; Hui P; Wong S; Abu-Khalaf M; Ravaggi A; Bignotti E; Bandiera E; Romani C; Todeschini P; Tassi R; Zanotti L; Odicino F; Pecorelli S; Donzelli C; Ardighieri L; Facchetti F; Falchetti M; Silasi DA; Ratner E; Azodi M; Schwartz PE; Mane S; Angioli R; Terranova C; Quick CM; Edraki B; Bilgüvar K; Lee M; Choi M; Stiegler AL; Boggon TJ; Schlessinger J; Lifton RP; Santin AD
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12238-12243. PubMed ID: 27791010
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 Expression in Carcinosarcomas of the Gynecologic Tract: A Potentially Actionable Biomarker.
Pinto A; Mackrides N; Nadji M
Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):393-397. PubMed ID: 27801734
[TBL] [Abstract][Full Text] [Related]
15. Inter-component immunohistochemical assessment of proliferative markers in uterine carcinosarcoma.
Pyra A; Adamiak-Godlewska A; Lewkowicz D; Bałon B; Cybulski M; Semczuk-Sikora A; Semczuk A
Oncol Lett; 2022 Oct; 24(4):363. PubMed ID: 36238851
[TBL] [Abstract][Full Text] [Related]
16. Expression of adhesion molecules and the proliferative activity of carcinosarcoma of the ovary.
Hirano H; Kizaki T; Ito T; Okimura A; Yamanegi K; Nakasho K
Anticancer Res; 2014 Dec; 34(12):7351-6. PubMed ID: 25503171
[TBL] [Abstract][Full Text] [Related]
17. Pathology of mixed Müllerian tumours.
D'Angelo E; Prat J
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):705-18. PubMed ID: 21742560
[TBL] [Abstract][Full Text] [Related]
18. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological studies of esophageal carcinosarcoma: analyses of its morphological characteristics using endoscopic, histological, and immunohistochemical procedures.
Chino O; Kijima H; Shimada H; Nishi T; Tanaka H; Oshiba G; Kise Y; Kenmochi T; Himeno H; Tsuchida T; Kawai K; Tanaka M; Machimura T; Tajima T; Makuuchi H
Endoscopy; 2000 Sep; 32(9):706-11. PubMed ID: 10989995
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and status of hormone receptors and angiogenic factors in uterine carcinosarcoma.
Etoh T; Nakai H
J Obstet Gynaecol Res; 2014 Mar; 40(3):820-5. PubMed ID: 24320058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
